Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471]

Qiang Niu,Yu Liu,Yujing Zheng,Ziwei Tang,Yuna Qian,Ruogu Qi,Jianliang Shen,Ping Zhao

DOI: https://doi.org/10.1016/j.apsb.2024.02.021

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.11.002.].

What problem does this paper attempt to address?

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Xiang P. Liu,Li J. Gao,Ben T. She,Gui X. Li,Yun R. Wu,Ji M. Xu,Zhong J. Ding,Jian F. Ma,Shao J. Zheng

DOI: https://doi.org/10.1111/pce.14419

2022-01-01

Abstract:In the published article, the author names in the byline which originally appeared as “Xiang P. Liu, Li J. Gao, Ben T. She, Gui X. Li, Yun R. Wu, Ji M. Xu, Zhong J. Ding, Jian F. Ma, Shao J. Zheng” have been corrected to “Xiangpei Liu, Lijun Gao, Bentao She, Guixin Li, Yunrong Wu, Jiming Xu, Zhongjie Ding, Jianfeng Ma, Shaojian Zheng” in the byline and the ORCID ID section. We apologize for this error.
Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747]

Bo Xiao,Yuqi Liang,Ga Liu,Lingshuang Wang,Zhan Zhang,Libin Qiu,Haiting Xu,Sean Carr,Xiaoxiao Shi,Rui L Reis,Subhas C Kundu,Zhenhua Zhu

DOI: https://doi.org/10.1016/j.apsb.2024.06.005

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2024.02.008.].
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]

Ying Hao,YuWen Chen,XinLong He,Fan Yang,RuXia Han,ChengLi Yang,Wei Li,ZhiYong Qian

DOI: https://doi.org/10.1016/j.bioactmat.2020.05.005

IF: 18.9

2021-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2020.04.002.].

engineering, biomedical,materials science, biomaterials
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

DOI: https://doi.org/10.1183/23120541.50555-2020

2021-12-06

Abstract:[This corrects the article DOI: 10.1183/23120541.00555-2020.].
Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Yifeng Xia,Jingnan An,Jiaying Li,Wenxing Gu,Yifan Zhang,Songsong Zhao,Cenzhu Zhao,Yang Xu,Bin Li,Zhiyuan Zhong,Fenghua Meng

DOI: https://doi.org/10.1016/j.bioactmat.2023.08.011

IF: 18.9

2024-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].
Erratum to: A novel GSH responsive poly(alpha-lipoic acid) nanocarrier bonding with the honokiol-DMXAA conjugate for combination therapy

Zhilin Liu,Zhaohui Tang,Dawei Zhang,Jiatan Wu,Xinghui Si,Na Shen,Xuesi Chen

DOI: https://doi.org/10.1007/s40843-020-1294-x

2020-04-22

Science China Materials

Abstract:In the version of the article originally published in the volume 63, issue 2, 2020 of Sci China Mater (2020, 63 (2): 307–315, https://doi.org/10.1007/s40843-019-1183-0), the affiliations of two of the authors (Zhaohui Tang and Xuesi Chen) were incompletely labeled. The corrected version of the authors’ affiliations is as below: Zhilin Liu1,2, Zhaohui Tang1,2*, Dawei Zhang1, Jiatan Wu3, Xinghui Si1,2, Na Shen1 and Xuesi Chen1,2*

materials science, multidisciplinary
Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts: Erratum

Jianbin Xu,Guolin Zhang,Xin Luo,Di Wang,Wei Zhou,Yan Zhang,Wei Zhang,Jiaxin Chen,Qing Meng,Engeng Chen,Heng Chen,Zhangfa Song

DOI: https://doi.org/10.7150/thno.76869

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.52076.].

medicine, research & experimental
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Zekun Li,Yongchun Pan,Shizheng Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qiang Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].
Erratum: A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents

Wang, Hai,Agarwal, Pranay,Zhao, Shuting,Yu, Jianhua,Lu, Xiongbin,He, Xiaoming

DOI: https://doi.org/10.1038/ncomms10350

IF: 16.6

2016-01-01

Nature Communications

Abstract:Nature Communications 6: Article number: 10081 (2015); Published: 1 December 2015; Updated: 7 January 2016 The original version of this Article contained an error in the spelling of ‘theranostic’ in the title of the paper. This has now been corrected in both the PDF and HTML versions of the Article.
Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Zhilin Li,Hao Cai,Zhiqian Li,Long Ren,Xuelei Ma,Hongyan Zhu,Qiyong Gong,Hu Zhang,Zhongwei Gu,Kui Luo

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.016

IF: 18.9

2023-04-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.028.].

engineering, biomedical,materials science, biomaterials
Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Yi Qian,Meimei Zhao,Qinghua Han,Jingkang Wang,Lixi Liao,Heng Yang,Dan Liu,Pengfei Tu,Hong Liang,Kewu Zeng

DOI: https://doi.org/10.1016/j.apsb.2024.02.013

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.01.011.].
Preparation of AS1411 Aptamer Modified Mn-MoS2 QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma [Corrigendum]

Shaohui Zheng,Min Zhang,Hongyan Bai,Meijuan He,Lina Dong,Lulu Cai,Mingming Zhao,Qi Wang,Kai Xu,Jingjing Li

DOI: https://doi.org/10.2147/ijn.s405918

IF: 7.033

2023-01-01

International Journal of Nanomedicine

Abstract:[This corrects the article DOI: 10.2147/IJN.S215883.].

pharmacology & pharmacy,nanoscience & nanotechnology
Author correction to ‘A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease’ [Acta Pharmaceutica Sinica B 12 (2021) 4032‒4044]

Ting Lei,Zhihang Yang,Xue Xia,Yuxiu Chen,Xiaotong Yang,Rou Xie,Fan Tong,Xiaolin Wang,Huile Gao

DOI: https://doi.org/10.1016/j.apsb.2022.04.008

IF: 14.903

2022-04-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.04.022.].

pharmacology & pharmacy
Erratum: A thermosensitive, reactive oxygen species-responsive, MR409-encapsulated hydrogel ameliorates disc degeneration in rats by inhibiting the secretory autophagy pathway: Erratum

Qiangqiang Zheng,Haotian Shen,Zongrui Tong,Linxiang Cheng,Yuzi Xu,Zhiyun Feng,Shiyao Liao,Xiaojian Hu,Zongyou Pan,Zhengwei Mao,Yue Wang

DOI: https://doi.org/10.7150/thno.103020

IF: 11.6

2024-09-12

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.47723.].
Erratum: Author correction to "Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry" [Acta Pharmaceutica Sinica B 10 (2020) 789-798]

Ke Tang,Xiaoyu Zhang,Ying Guo

DOI: https://doi.org/10.1016/j.apsb.2024.04.012

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.02.014.].
Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Qi Chang Zheng,Shuai Jiang,Yu Zhe Wu,Dan Shang,Yong Zhang,Shao Bo Hu,Xiang Cheng,Chen Zhang,Ping Sun,Yang Gao,Zi Fang Song,Min Li

DOI: https://doi.org/10.3389/fbioe.2021.656268

IF: 5.7

2021-02-11

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00512.].

multidisciplinary sciences

Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471]

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747]

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Erratum to: A novel GSH responsive poly(alpha-lipoic acid) nanocarrier bonding with the honokiol-DMXAA conjugate for combination therapy

Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts: Erratum

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Erratum: A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Preparation of AS1411 Aptamer Modified Mn-MoS2 QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma [Corrigendum]

Author correction to ‘A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease’ [Acta Pharmaceutica Sinica B 12 (2021) 4032‒4044]

Erratum: A thermosensitive, reactive oxygen species-responsive, MR409-encapsulated hydrogel ameliorates disc degeneration in rats by inhibiting the secretory autophagy pathway: Erratum

Erratum: Author correction to "Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry" [Acta Pharmaceutica Sinica B 10 (2020) 789-798]

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]